Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.

Ignacio Conget, Pilar Martín-Vaquero,Stéphane Roze,Isabel Elías, Cristina Pineda,María Álvarez,Alexis Delbaere,Francisco Javier Ampudia-Blasco

Endocrinología, Diabetes y Nutrición (English ed.)（2018）

引用 7|浏览7

暂无评分

摘要

From both the Spanish NHS perspective and the societal perspective, SAP with low glucose suspend is a cost-effective option for the treatment of T1DM patients at high risk of hypoglycemia.

查看译文

关键词

Type 1 diabetes mellitus,Continuous subcutaneous insulin infusion,Sensor-augmented pump with low glucose suspend,Hypoglycemia,Cost-utility,Spain

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要